silybin has been researched along with MPTP Neurotoxicity Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chavarría, A; García, E; Meza, C; Pérez-Ramírez, DJ; Ramírez-Carreto, RJ; Rodríguez-López, BE; Santamaría, A; Zaldívar-Machorro, VJ | 1 |
Chun, HJ; Lee, J; Lee, Y; Park, HR | 1 |
Chun, HJ; Jung, YS; Lee, J; Lee, KM; Lee, Y | 1 |
3 other study(ies) available for silybin and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Oral Administration of Silybin Protects Against MPTP-Induced Neurotoxicity by Reducing Pro-inflammatory Cytokines and Preserving BDNF Levels in Mice.
Topics: Administration, Oral; Animals; Brain-Derived Neurotrophic Factor; Cytokines; Disease Models, Animal; Dopamine; Mice; MPTP Poisoning; Neurodegenerative Diseases; Silybin | 2023 |
Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization.
Topics: Actins; Animals; Antioxidants; Calcium-Binding Proteins; Cell Death; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Dopaminergic Neurons; Embryo, Mammalian; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Mitochondria; Mitochondrial Trifunctional Protein; Motor Activity; MPTP Poisoning; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Silybin; Silymarin | 2015 |
Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Animals, Newborn; Antioxidants; Astrocytes; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; Rats, Sprague-Dawley; Silybin; Silymarin; Time Factors; Tyrosine 3-Monooxygenase | 2015 |